IvanTCakulevMD
Cardiology • Cleveland, OHAdult Congenital Heart Disease, Cardiac Electrophysiology
Assistant Professor, Medicine, Case Western Reserve University School of Medicine
Dr. Cakulev is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Ave
Cleveland, OH 44106Phone+1 216-844-8500
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2002 - 2004
Baylor College of MedicineFellowship, Cardiovascular Disease, 1998 - 2002
Cleveland Clinic FoundationResidency, Internal Medicine, 1994 - 1997
OtherClass of 1993
University Kiril and Metodij Faculty of MedicineClass of 1992
Certifications & Licensure
OH State Medical License 2002 - 2025
TX State Medical License 2000 - 2003- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Clinical Cardiac Electrophysiology
Publications & Presentations
PubMed
- 21 citationsEHRA consensus on prevention and management of interference due to medical procedures in patients with cardiac implantable electronic devices.Markus Stühlinger, Haran Burri, Kevin Vernooy, Rodrigue Garcia, Radoslaw Lenarczyk
Europace. 2022-10-13 - 7 citationsEbstein's Anomaly: Review of Arrhythmia Types and Morphogenesis of the AnomalyBeixin Julie He, Alexander F Merriman, Ivan Cakulev, Bruce S. Stambler, Deepak Srivastava
JACC. Clinical Electrophysiology. 2021-08-17 - 2 citationsWhat Is It About Women?: The Antiarrhythmic Effect of Cardiac Resynchronization Therapy.Judith A. Mackall, Ivan Cakulev
JACC. Clinical Electrophysiology. 2021-06-01
Press Mentions
University Hospitals Using New Heart Failure Therapy Designed to Improve Patients’ Quality of LifeJuly 6th, 2021- Ohio Health System Among 1st in US to Use Novel Heart Failure TherapyJune 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
